High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid.

Published on Jul 27, 2021in Endocrine Pathology3.168
· DOI :10.1007/S12022-021-09688-9
Ja-Seong Bae12
Estimated H-index: 12
(Catholic University of Korea),
Seung-Hyun Jung20
Estimated H-index: 20
(Catholic University of Korea)
+ 5 AuthorsChan Kwon Jung37
Estimated H-index: 37
(Catholic University of Korea)
Sources
Abstract
Follicular-patterned tumors of the thyroid in the adult population frequently harbor RAS mutations or PAX8-PPARG rearrangement, but little is known about molecular profiles in the pediatric patients with thyroid tumors, which is rare. To identify the molecular profile of pediatric follicular-patterned tumors, we enrolled 41 pediatric patients with follicular-patterned tumors from two institutions. We did next-generation sequencing using a mutation panel targeting 49 thyroid-tumor-related genes and a fusion panel targeting 88 types of thyroid-related gene fusions. We identified nonsynonymous mutations in at least one target gene in most of the tumors (28/41, 68%). Somatic DICER1 mutations (22%, n = 9) were the most common genetic alteration, followed by mutations of NRAS (15%), FGFR3 (15%), PTEN (12%), and STK11 (10%). Infrequent genetic alterations (≤ 5% of all cases) included mutations of HRAS, APC, TSHR, CTNNB1, TP53, EIF1AX, FGFR4, GNAS, RET, and SOS1, and gene fusion of THADA-IGF2BP3. DICER1 and RAS mutations were mutually exclusive. No patients had tumors related to the DICER1 syndrome or the Cowden syndrome. There was no significant difference in total mutation burden or distribution between follicular adenoma and follicular carcinoma. In the literature, the DICER1 mutation has been reported in 20 to 53% of pediatric patients with follicular-patterned tumors. In conclusion, our study reinforces the role of the DICER1 mutation in the development of pediatric thyroid tumors. Gene fusions rarely occur in pediatric follicular-patterned tumors. Mutation or gene fusion alone could not distinguish benign from malignant follicular-patterned tumors in pediatric patients.
📖 Papers frequently viewed together
22 Citations
2016
14 Authors (Roxana Marino, ..., Alicia Belgorosky)
30 Citations
References41
Newest
#1Huy Gia Vuong (OU: University of Oklahoma)H-Index: 15
#2Duy Giang Bao Chung (Pham Ngoc Thach University of Medicine)H-Index: 1
Last. Andrey Bychkov (Chula: Chulalongkorn University)H-Index: 16
view all 8 authors...
Background Little is known about the application of The Bethesda System for Reporting Thyroid Classification (TBSRTC) in pediatric thyroid nodules. This meta-analysis was aimed to investigate the use of TBSRTC in the pediatric population. Methods Relevant articles were searched in PubMed and Web of Science. Meta-analysis of proportion and its 95% confidence interval (CI) were computed utilizing the random-effect model. We used subgroup analyses and meta-regression to explore the sources of heter...
4 CitationsSource
#1Paula Soares (University of Porto)H-Index: 59
Last. Manuel Sobrinho-SimõesH-Index: 80
view all 8 authors...
This review addresses the impact of molecular alterations on the diagnosis and prognosis of differentiated thyroid carcinoma (DTC), including papillary, follicular, and well-differentiated carcinoma NOS, as well as oncocytic neoplasms. The molecular characterization of DTC is based upon the well-established dichotomy of BRAF-like and RAS-like designations, together with a remaining third group, less homogeneous, composed of non-BRAF-/non-RAS-like tumors. The role of BRAF V600E mutation in risk s...
5 CitationsSource
#1Yoo-Jin Kim (Catholic University of Korea)H-Index: 24
#2Seung-Hyun Jung (Catholic University of Korea)H-Index: 20
Last. Je-Hwan Lee (UOU: University of Ulsan)H-Index: 42
view all 12 authors...
Abstract Recent advancements in next-generation sequencing (NGS) technologies allow the simultaneous identification of targeted copy number alterations (CNAs) as well as somatic mutations using the same panel-based NGS data. We investigated whether CNAs detected by the targeted NGS data provided additional clinical implications, over somatic mutations, in myelodysplastic syndrome (MDS). Targeted deep sequencing of 28 well-known MDS-related genes was performed for 266 patients with MDS. Overall, ...
1 CitationsSource
#1Xiaonan Zhao (Children's Hospital of Philadelphia)H-Index: 3
#2Chelsea Kotch (Children's Hospital of Philadelphia)H-Index: 1
Last. Portia A. Kreiger (Children's Hospital of Philadelphia)H-Index: 18
view all 19 authors...
PURPOSENeurotrophic tyrosine receptor kinase (NTRK) fusions have been described as oncogenic drivers in a variety of tumors. However, little is known about the overall frequency of NTRK fusion in u...
3 CitationsSource
#1Barbora PekovaH-Index: 2
#2Vlasta SykorovaH-Index: 8
Last. Bela BendlovaH-Index: 21
view all 11 authors...
BACKGROUND Pediatric papillary thyroid carcinoma (PTC) is a rare malignancy but with an increasing incidence. Pediatric PTCs have distinct clinical and pathological features and even the molecular profile differs from adult PTCs. Somatic point mutations in pediatric PTCs have been previously described and studied, but complex information about fusion genes is lacking. The aim of this study was to identify different fusion genes in a large cohort of pediatric PTCs and to correlate them with clini...
22 CitationsSource
#1Huy Gia Vuong (OU: University of Oklahoma)H-Index: 15
#2Ayana SuzukiH-Index: 9
Last. Andrey BychkovH-Index: 16
view all 15 authors...
Objectives We aimed to provide the Asian experience with the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in pediatric thyroid nodules. Methods Consecutive thyroid fine-needle aspirates (patient age, ≤18 years) were retrospectively collected from 7 tertiary centers in 5 Asian countries. Results Of 194,364 thyroid aspirates, 0.6% were pediatric cases (mean age, 15.0 years). Among 827 nodules with accessible follow-up, the resection rate and risk of malignancy (ROM) were 36.3% and ...
3 CitationsSource
#1Chan Kwon Jung (Catholic University of Korea)H-Index: 37
#2Seung-Hyun Jung (Catholic University of Korea)H-Index: 20
Last. Yeun-Jun Chung (Catholic University of Korea)H-Index: 27
view all 8 authors...
BACKGROUND: Although most differentiated thyroid cancers (DTCs) have indolent behavior, DTCs with distant metastasis have a poor prognosis. However, there are no validated markers that predict the risk of distant metastasis and the prognosis of DTC. We aimed to develop a genetic classifier for predicting the outcomes of DTC patients with distant metastases. METHODS: Targeted deep-sequencing of 157 cancer-related genes was performed for 61 DTCs with distant metastases. A candidate mutation was va...
9 CitationsSource
#1Yanhua Bai (PKU: Peking University)H-Index: 14
#2Kennichi KakudoH-Index: 33
Last. Chan Kwon Jung (Catholic University of Korea)H-Index: 37
view all 3 authors...
Advances in medical sciences and evidence-based medicine have led to momentous changes in classification and management of thyroid neoplasms. Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers. The new 2017 World Health Organization (WHO) classification of thyroid neoplasms updated the diagnostic criteria and molecular and genetic characteristics reflecting the biology and behavior of the tumors, and newly introduced the category of borderline malignan...
2 CitationsSource
#1Vania Nosé (Harvard University)H-Index: 27
3 CitationsSource
#1Eleni I Theotoki (UoA: National and Kapodistrian University of Athens)H-Index: 1
#2Vasiliki I. Pantazopoulou (Academy of Athens)H-Index: 2
Last. Ema Anastasiadou (Academy of Athens)H-Index: 12
view all 7 authors...
Gene expression dictates fundamental cellular processes and its de-regulation leads to pathological conditions. A key contributor to the fine-tuning of gene expression is Dicer, an RNA-binding protein (RBPs) that forms complexes and affects transcription by acting at the post-transcriptional level via the targeting of mRNAs by Dicer-produced small non-coding RNAs. This review aims to present the contribution of Dicer protein in a wide spectrum of human pathological conditions, including cancer, ...
4 CitationsSource
Cited By1
Newest
#1Charles A. Ghossein (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 1
#2Snjezana Dogan (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 24
Last. Bin Xu (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 25
view all 5 authors...
DICER1 gene encodes an RNaseIII endoribonuclease essential for the cleavage of pre-microRNA to mature microRNA. Germline DICER1 mutation results in DICER syndrome, a cancer predisposition syndrome which manifests in the thyroid gland as early-onset multinodular goiter and increased risk for differentiated thyroid carcinoma. Recently, somatic DICER1 mutations were described in various thyroid neoplasms, including follicular adenoma, papillary thyroid carcinoma, follicular carcinoma, and poorly di...
Source